Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe publications note at the bottom was updated to indicate PubMed-listed publications are automatically filled from PubMed and may not be about the study, and the revision version changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoval of a site-wide banner about government funding and operating status from the page. This does not affect the study details or the core information presented about the Nivo40 trial.SummaryDifference0.4%

- Check42 days agoChange DetectedThe screenshots show only UI/layout updates with no changes to the study's core details (eligibility criteria, endpoints, or results). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedThe page now includes a funding-related operating status notice and a new version badge (v3.2.0), replacing the previous v3.1.0. This signals updated operational status and a software release, altering expectations for data processing and reliability.SummaryDifference5%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top link was removed, with no other substantive changes.SummaryDifference0.3%

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.